Skip to content
Medical Health Aged Care

Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024

Aster DM Healthcare 2 mins read
DUBAI, United Arab Emirates--BUSINESS WIRE--

Aster Guardians Global Nursing Award has today unveiled the top 10 finalists for 2024, one of whom will go on to win the grand title award of US $ 250,000. These 10 nurses have been shortlisted from a pool of 78,000 nurses from 202 countries across the world, following a stringent review process run independently by Ernst & Young LLP, a Screening jury and the Grand jury.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241015152556/en/

Top 10 finalist nurses for Aster Guardians Global Nursing Award 2024 (Photo: AETOSWire)

Top 10 finalist nurses for Aster Guardians Global Nursing Award 2024 (Photo: AETOSWire)

The top 10 finalists for 2024 includes: Archimedes Motari (Kenya), Johnsy Inni (Papua New Guinea), Laarni Conlu Florencio (USA), Lilian Nuwabaine (Uganda), Nelson Bautista (UAE), Nilima Pradeepkumar Rane (India), Maria Victoria Juan (Philippines), Martin Schiavenato (USA), Hoi Shu Yin (Singapore) and Sylvia May Hampton (UK). To know more about the top 10 finalists, please visit: https://www.asterguardians.com/

Dr Azad Moopen, Founder Chairman, Aster DM Healthcare, said, “Each and every one of these nurses have showcased excellence – going above and beyond their duties for the wellbeing of patients and the community. The Aster Guardians Global Nursing Award was established with this very aim – to honour, celebrate and reward the remarkable contributions of nurses and establish them as role models in the field of nursing.”

He also added, “With more than 9000 nurses working across Aster DM Healthcare’s facilities across 7 countries, we have witnessed the commitment and efforts put in by nurses very closely. This is the least we can do to shine a spotlight on the work being done by the nursing community globally.”

The final round will include interviews with respected members of the Grand Jury, and the winner will be announced at a gala event in Bengaluru, India by December 2024.

About Aster DM Healthcare:

Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across seven countries. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of “We will treat you well”.

Source: AETOSWire


Contact details:

Aster DM Healthcare
Lavanya Mandal
Head of PR and Internal Communications, +971528126577
Email: lavanya.mandal@asterdmhealthcare.com

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.